Clasp Therapeutics Funding: $150M Raised, Series A (2024)
Clasp Therapeutics is a Biotech company based in Cambridge, MA. It has raised $150M in total funding. Latest round: Series A.
Clasp Therapeutics funding overview
Clasp Therapeutics is a Biotech company based in Cambridge, MA. Clasp Therapeutics has raised $150M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in March 2024. The round record for Clasp Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Third Rock Ventures, Novo Holdings, Catalio Capital Management. 3 distinct backers are named across the disclosed rounds.
Clasp Therapeutics at a glance
Total raised
$150M
Latest round
Series A
Latest round date
March 2024
Industry
Biotech
Headquarters
Cambridge, MA
Notable investors
Third Rock Ventures, Novo Holdings, Catalio Capital Management
Frequently asked about Clasp Therapeutics funding
How much has Clasp Therapeutics raised?
Clasp Therapeutics has raised $150M in total disclosed funding across the rounds on record.
Who has invested in Clasp Therapeutics?
Third Rock Ventures, Novo Holdings, Catalio Capital Management are named among the investors backing Clasp Therapeutics.
What was the latest Clasp Therapeutics funding round?
The most recent disclosed round is a Series A, announced in March 2024.
Where is Clasp Therapeutics based?
Clasp Therapeutics is based in Cambridge, MA.
What sector does Clasp Therapeutics operate in?
Clasp Therapeutics is tracked under Biotech from Cambridge, MA, with $150M in disclosed funding.
When did Clasp Therapeutics last raise?
The last disclosed Clasp Therapeutics round closed in March 2024 at Series A.
We update the Clasp Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in Cambridge and their backers are listed below.
